NBY logo

NovaBay Pharmaceuticals, Inc. (NBY)

Profile

Full Name

NovaBay Pharmaceuticals, Inc.

Ticker

NYSEAmerican: NBY

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 26, 2007

Indexes

Not included

Website

https://novabay.com

Employees

13

Key Details

Price

$0.60(-3.23%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$9.78M(-6.45% YoY)

Annual EPS

-$2.53(+98.18% YoY)

PE ratio

1.22

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.60
    NBY price is $0.60

    30-Day Relative Volume

    0.89
    NBY 30-day relative volume is 0.89

    Price Performance

    Price Today change

    -3.23%
    NBY price is down -3.23% today

    Price YTD change

    0%
    NBY price has remained unchanged since January 1st

    Price 1-year change

    +1.69%
    NBY price is up +1.69% year-on-year

    Price 3-year change

    -99.81%
    NBY price is down -99.81% over the past 3 years

    Price Range

    Price All-time high

    $130.16K
    NBY price is currently -100.00% below its historical high of $130.16 thousand

    Price 3-year low

    $0.36
    NBY price is currently +66.67% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.49M
    NBY market capitalization is $3.49 million

    Market cap 3-year change

    -74.93%
    NBY market capitalization is down -74.93% over the past 3 years

    Market cap All-time high

    $85.54M
    NBY market capitalization is currently -95.92% below its historical high of $85.54 million

    Market cap sector rank

    7.46%
    NBY market capitalization is higher than 7.46% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +19.05%
    NBY shares outstanding is up +19.05% year-on-year

    Shares Outstanding 3-Year Change

    +13209.38%
    NBY shares outstanding is up +13209.38% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.43
    NBY beta is 0.43

    200-day SMA

    $0.62
    NBY price is currently -3.09% below its 200-day simple moving average

    50-day SMA

    $0.62
    NBY price is currently -3.13% below its 50-day simple moving average

    RSI

    47.48
    NBY 14-day relative strength index is 47.48

    Volume

    0.89
    NBY 30-day relative volume is 0.89

    ATR

    $0.05
    NBY average true range is $0.05

    10-day Historical Volatility

    39.27%
    NBY 10-day historical volatility is 39.27%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $9.78M
    NBY annual revenue is $9.78 million

    Revenue Analysts estimate

    -
    NBY annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -6.45%
    NBY annual revenue is down -6.45% year-on-year

    Revenue Sector rank

    47.61%
    NBY annual revenue is higher than 47.61% of companies in Healthcare sector

    EPS

    EPS

    -$2.53
    NBY annual earnings per share is -$2.53

    EPS Analysts estimate

    -
    NBY annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +98.18%
    NBY annual earnings per share is up +98.18% year-on-year

    EPS Sector rank

    33.22%
    NBY annual earnings per share is higher than 33.22% of companies in Healthcare sector

    Profit

    Gross profit

    $6.48M
    NBY annual gross profit is $6.48 million

    Gross margin

    66.26%
    NBY annual gross profit margin is 66.26%

    Operating profit

    -$4.97M
    NBY annual operating income is -$4.97 million

    Operating margin

    -50.85%
    NBY annual operating profit margin is -50.85%

    Net income

    -$7.21M
    NBY annual net profit is -$7.21 million

    Net margin

    -73.71%
    NBY annual net profit margin is -73.71%

    Expenses

    Total expenses

    $16.99M
    NBY annual total expenses is $16.99 million

    Operating expenses

    $11.46M
    NBY annual total operating expenses is $11.46 million

    Cost of goods sold

    $3.30M
    NBY annual cost of goods sold is $3.30 million

    Selling, general & administrative expenses

    $0.00
    NBY annual SGA is $0.00

    Depreciation and amortization

    $381.00K
    NBY annual depreciation & amortization is $381.00 thousand

    Interest expense

    $0.00
    NBY annual interest expense is $0.00

    Income tax

    $0.00
    NBY annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$6.31M
    NBY annual earnings before interest & taxes is -$6.31 million

    EBITDA

    -$4.59M
    NBY annual EBITDA is -$4.59 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $45.91M
    NBY annual total assets is $45.91 million

    Non current assets

    $43.97M
    NBY annual long term assets is $43.97 million

    Current assets

    $1.94M
    NBY annual total current assets is $1.94 million

    Cash and cash equivalents

    $430.00K
    NBY annual cash & cash equivalents is $430.00 thousand

    Accounts receivable

    $389.00K
    NBY annual accounts receivable is $389.00 thousand

    Inventory

    $765.00K
    NBY annual inventory is $765.00 thousand

    Liabilities

    Total liabilities

    $46.03M
    NBY annual total liabilities is $46.03 million

    Long term liabilities

    $43.19M
    NBY annual total long term liabilities is $43.19 million

    Current liabilities

    $2.84M
    NBY annual total current liabilities is $2.84 million

    Accounts payable

    $623.00K
    NBY annual accounts payable is $623.00 thousand

    Debt

    Total debt

    $1.67M
    NBY annual total debt is $1.67 million

    Total debt 1-year change

    -36.01%
    NBY annual total debt is down -36.01% year-on-year

    Long term debt

    $709.00K
    NBY annual long term debt is $709.00 thousand

    Short term debt

    $963.00K
    NBY annual short term debt is $963.00 thousand

    Equity & Capital

    Shareholders equity

    -$129.00K
    NBY annual stockholders equity is -$129.00 thousand

    Book value

    -$135.00K
    NBY annual book value is -$135.00 thousand

    Retained earnings

    -$183.46M
    NBY annual retained earnings is -$183.46 million

    Working capital

    -$908.00K
    NBY annual working capital is -$908.00 thousand

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$5.18M
    NBY annual cash flow from operations is -$5.18 million

    Cash from operations 1-year change

    -21.64%
    NBY annual cash flow from operations is down -21.64% year-on-year

    Cash from investing

    $1.06M
    NBY annual cash flow from investing activities is $1.06 million

    Cash from investing 1-year change

    +5700%
    NBY annual cash flow from investing activities is up +5700% year-on-year

    Cash from financing

    $1.50M
    NBY annual cash flow from financing activities is $1.50 million

    Cash from financing 1-year change

    -21.47%
    NBY annual cash flow from financing activities is down -21.47% year-on-year

    CAPEX

    CAPEX

    $6000.00
    NBY annual capital expenditures is $6000.00

    CAPEX 1-year change

    -68.42%
    NBY annual capital expenditures is down -68.42% year-on-year

    Free Cash Flow

    Free cash flow

    -$5.19M
    NBY annual free cash flow is -$5.19 million

    Free cash flow 1-year change

    -21.24%
    NBY annual free cash flow is down -21.24% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    66.26%
    NBY annual gross profit margin is 66.26%

    Operating margin

    -50.85%
    NBY annual operating profit margin is -50.85%

    Net margin

    -73.71%
    NBY annual net profit margin is -73.71%

    ROA & ROE

    ROA

    -14.97%
    NBY annual return on assets is -14.97%

    ROE

    -452.75%
    NBY annual return on equity is -452.75%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    1.22
    NBY price to earnings ratio is 1.22

    PE ratio Sector rank

    4.23%
    NBY price to earnings ratio is higher than 4.23% of companies in Healthcare sector

    PB Ratio

    PB ratio

    0.82
    NBY price to book ratio is 0.82

    PB ratio Sector rank

    32.75%
    NBY price to book ratio is higher than 32.75% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.73
    NBY price to sales ratio is 0.73

    PS ratio Sector rank

    17.89%
    NBY price to sales ratio is higher than 17.89% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -$1.99M
    NBY enterprise value is -$1.99 million

    Enterprise value Sector rank

    12.35%
    NBY enterprise value is higher than 12.35% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.29
    NBY EV/EBITDA is 0.29

    EV/EBITDA Sector rank

    67.38%
    NBY EV/EBITDA is higher than 67.38% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.68
    NBY annual current ratio is 0.68

    Quick ratio

    0.41
    NBY annual quick ratio is 0.41

    Leverage

    Debt to equity

    -12.96
    NBY annual debt to equity ratio is -12.96

    Interest coverage ratio

    -
    NBY annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    NBY piotroski f-score value is unknown

    Altman Z-Score

    -5.81
    NBY altman z-score is -5.81

    Analyst ratings

    Recent major analysts updates

    Nov 11, 24 Ascendiant Capital
    Buy
    Aug 11, 23 Ladenburg Thalmann
    Buy
    May 20, 22 Ascendiant Capital
    Buy
    Sep 18, 19 Ladenburg Thalmann
    Buy
    Mar 13, 19 H.C. Wainwright
    Neutral
    Mar 26, 18 Roth Capital
    Neutral
    Jun 5, 17 Roth Capital
    Buy
    Mar 7, 16 Maxim Group
    Hold
    Apr 30, 15 Maxim Group
    Buy
    Mar 6, 13 Ascendiant Capital
    Strong Buy

    Institutional Ownership

    Screeners with NBY included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    Healthcare sector
    All stocks
    Biotech Companies
    Ex Dividend dates calendar
    Small cap stocks
    • What is the ticker symbol for NovaBay Pharmaceuticals, Inc.?
    • Does NovaBay Pharmaceuticals, Inc. pay dividends?
    • What sector is NovaBay Pharmaceuticals, Inc. in?
    • What industry is NovaBay Pharmaceuticals, Inc. in?
    • What country is NovaBay Pharmaceuticals, Inc. based in?
    • When did NovaBay Pharmaceuticals, Inc. go public?
    • Is NovaBay Pharmaceuticals, Inc. in the S&P 500?
    • Is NovaBay Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is NovaBay Pharmaceuticals, Inc. in the Dow Jones?
    • When was NovaBay Pharmaceuticals, Inc.'s last earnings report?
    • When does NovaBay Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for NovaBay Pharmaceuticals, Inc.?

    The ticker symbol for NovaBay Pharmaceuticals, Inc. is NYSEAmerican:NBY

    Does NovaBay Pharmaceuticals, Inc. pay dividends?

    No, NovaBay Pharmaceuticals, Inc. does not pay dividends

    What sector is NovaBay Pharmaceuticals, Inc. in?

    NovaBay Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is NovaBay Pharmaceuticals, Inc. in?

    NovaBay Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is NovaBay Pharmaceuticals, Inc. based in?

    NovaBay Pharmaceuticals, Inc. is headquartered in United States

    When did NovaBay Pharmaceuticals, Inc. go public?

    NovaBay Pharmaceuticals, Inc.'s initial public offering (IPO) was on October 26, 2007

    Is NovaBay Pharmaceuticals, Inc. in the S&P 500?

    No, NovaBay Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is NovaBay Pharmaceuticals, Inc. in the NASDAQ 100?

    No, NovaBay Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is NovaBay Pharmaceuticals, Inc. in the Dow Jones?

    No, NovaBay Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was NovaBay Pharmaceuticals, Inc.'s last earnings report?

    NovaBay Pharmaceuticals, Inc.'s most recent earnings report was on August 12, 2025

    When does NovaBay Pharmaceuticals, Inc. report earnings?

    The date for NovaBay Pharmaceuticals, Inc.'s next earnings report has not been announced yet
    On this page